Probiotics – Strategies for Global Regulatory Compliance
Globally probiotic products have shown exception growth driven by growing awareness of health benefits of microbiome-based products for multiple health, […]
Biopharmaceutical Alliance Launched by India, South Korea, US, Japan, and EU
The global biopharmaceutical sector has taken a significant step towards ensuring a resilient drug supply chain with the formation of
Artixio’s Regulatory Support for a Chinese Pharmaceutical Manufacturer in Mexico
A case study outlining Artixio’s Regulatory Support for a Chinese client: Client: Pharmaceutical Manufacturer Problem Statement A Chinese Pharmaceutical Manufacturer,
COFEPRIS Advertising Permission for Food Supplements in Mexico
If you’re a natural or legal person providing health services, beautification procedures, or promoting the consumption or sale of various
Artificial Intelligence Impact on Global Pharma Regulatory Affairs
Artificial Intelligence (AI) has been making significant strides across various sectors, and the pharma industry is no exception. One area
Registration of Biologics in Malaysia (NPRA)
Biologics have emerged as a significant treatment for various diseases in Malaysia. With their increasing relevance in addressing chronic diseases
FAQs: Malaysia MDA Regulations for Medical Device Registration
Here are answers to some of the Frequently Asked Questions (FAQs) about Malaysia regulations for Medical Device registration. MDA Registration
Thai FDA Updates Medical Device Advertising Rules – Jan, 2025
The Food and Drug Administration Announcement RE: Determination of Criteria, Conditions, and Requirements for Approval, Issuance of License, and License
Pharmaceutical Regulations and Registration in Malaysia
Before placing a pharmaceutical product on the Malaysian market, it’s important to understand how the local regulatory system works. The